Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.494,71
0,96%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aclarion Inc (ACON) Aclarion Inc (ACON) Notizie

Aclarion Inc

ACON
0,293
0,0102 (3,61%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202415:14GLOBEAclarion’s Nociscan Solution to Play Key Role in..
06/3/202422:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/3/202414:00GLOBEAclarion Announces Publication of Compelling Peer-Reviewed..
27/2/202421:22GLOBEAclarion Announces Closing of $3.0 Million Public Offering
27/2/202420:00EDGAR2Form 8-K - Current report
27/2/202416:46EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
27/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/2/202415:15GLOBEAclarion Announces Pricing of $3.0 Million Public Offering
23/2/202417:46EDGAR2Form S-1/A - General form for registration of securities..
21/2/202423:25EDGAR2Form 8-K - Current report
21/2/202421:02EDGAR2Form S-1/A - General form for registration of securities..
06/2/202423:32EDGAR2Form S-1/A - General form for registration of securities..
05/2/202414:00GLOBEAclarion Announces Successful Financings; Plans to Launch..
01/2/202423:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/1/202423:26EDGAR2Form S-1/A - General form for registration of securities..
29/1/202412:04EDGAR2Form 8-K - Current report
23/1/202415:53EDGAR2Form 8-K - Current report
22/1/202422:48EDGAR2Form S-1 - General form for registration of securities under..
22/1/202414:00GLOBEAclarion Expands Nociscan Access Into Phoenix With Key..
17/1/202414:00GLOBEAclarion Announces Updated Product Release That Expands MRI..
12/1/202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202414:00GLOBEAclarion and ATEC Execute Strategic Partnership Agreement to..
04/1/202414:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/1/202414:00EDGAR2Form 8-K - Current report
02/1/202418:00GLOBEAclarion Announces Reverse Stock Split
29/12/202312:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/12/202322:30EDGAR2Form 8-K - Current report
11/12/202322:55EDGAR2Form S-1 - General form for registration of securities under..
27/11/202314:00GLOBEAclarion Announces Key Commercial Milestone With Completion..
22/11/202322:01EDGAR2Form 8-K - Current report
16/11/202322:58EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/11/202312:00EDGAR2Form DEF 14A - Other definitive proxy statements
08/11/202314:00GLOBEAclarion Announces Achievement of Goal to Enroll 10 Leading..
06/11/202314:00GLOBEAclarion Expands Immediate Nociscan Access Into New York..
01/11/202321:15EDGAR2Form PRE 14A - Other preliminary proxy statements
01/11/202313:00GLOBEAclarion Presents at the NIH HEAL Initiative Fall Meeting
30/10/202322:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
25/10/202314:30GLOBEAclarion Announces Signing of Commercial Agreement With..
24/10/202314:45GLOBEAclarion Announces Nociscan® Cost-Effectiveness Poster..
23/10/202314:55EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/10/202313:00GLOBEAclarion Announces Signing Strategic Partnership Letter of..
23/10/202312:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/10/202321:08EDGAR2Form S-1/A - General form for registration of securities..
10/10/202321:34EDGAR2Form S-1 - General form for registration of securities under..
10/10/202314:30EDGAR2Form 8-K - Current report
02/10/202314:00GLOBEAclarion Provides Updated Investor Presentation and..
28/9/202313:48EDGAR2Form 8-K - Current report
07/9/202322:01EDGAR2Form 8-K - Current report
31/8/202322:01EDGAR2Form 8-K - Current report
25/8/202322:42EDGAR2Form 8-K - Current report
Apertura: 0,30 Min: 0,2845 Max: 0,30
Chiusura: 0,2828

La tua Cronologia

NASDAQ
ACON
Aclarion
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network